BBLG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bone Biologics Corp (BBLG) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available. The stock is currently in a bearish trend with no positive technical or fundamental indicators to support a buy decision. Additionally, the company's financial performance is weak, and there are no recent positive catalysts or trading signals.
The stock is in a bearish trend with MACD negatively expanding, RSI indicating oversold conditions at 12.608, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.257 and 1.139, with resistance at 1.448 and 1.639. The stock has a 70% chance to decline further in the short term.
NULL identified. No recent news or significant insider/hedge fund activity.
Weak financial performance in Q3 2025, with net income dropping by -83.95% YoY and EPS down by -97.40% YoY. No recent news or positive trading signals. Stock trend analysis suggests further short-term declines.
In Q3 2025, revenue remained at 0 with no growth, net income dropped to -666,737 (-83.95% YoY), and EPS fell to -0.37 (-97.40% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target data available.
